Suanfarma

Suanfarma

Madrid, Spain· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Suanfarma is a well-established, revenue-generating Spanish pharmaceutical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) and offering CDMO services. With a global presence serving over 400 customers in 75+ countries, it leverages advanced manufacturing facilities in Portugal (Cipan) and Italy (Rovereto) and maintains a strong commitment to regulatory quality and R&D. The company's strategy centers on being a reliable European source for both generic and innovative APIs, supported by a focus on sustainability and technological innovation in pharmaceutical production.

Small MoleculesDrug Delivery

Technology Platform

Advanced manufacturing and process development for small molecule APIs and drug delivery systems, supported by stringent regulatory and quality systems.

Opportunities

Growing demand for reliable European API manufacturing due to supply chain reshoring trends.
Expansion of the global CDMO market as pharma companies increase outsourcing.
Increased need for sustainable and technologically advanced production processes.

Risk Factors

Regulatory non-compliance at manufacturing facilities could halt operations and damage reputation.
Exposure to volatile raw material costs and global supply chain disruptions.
Intense competition in the API and CDMO space may pressure pricing and margins.

Competitive Landscape

Competes with large global CDMOs (e.g., Lonza, Catalent) and specialized API manufacturers, particularly in Europe and Asia. Differentiation is based on high-quality standards, regulatory track record, integrated services, and positioning as a strategic European partner. Must also compete on cost efficiency against lower-cost region producers.